PMID- 24632340 OWN - NLM STAT- MEDLINE DCOM- 20150126 LR - 20220409 IS - 1532-8414 (Electronic) IS - 1071-9164 (Linking) VI - 20 IP - 6 DP - 2014 Jun TI - Predictors and outcomes of "super-response" to cardiac resynchronization therapy. PG - 379-86 LID - S1071-9164(14)00094-3 [pii] LID - 10.1016/j.cardfail.2014.03.001 [doi] AB - BACKGROUND: Cardiac resynchronization therapy (CRT) has been shown to improve heart failure (HF) symptoms and survival. We hypothesized that a greater improvement in left-ventricular ejection fraction (LVEF) after CRT is associated with greater survival benefit. METHODS AND RESULTS: In 693 patients across 2 international centers, the improvement in LVEF after CRT was determined. Patients were grouped as non-/modest-, moderate-, or super-responders to CRT, defined as an absolute change in LVEF of 15%, respectively. Changes in New York Heart Association (NYHA) functional class and left ventricular end-diastolic dimension (LVEDD) were assessed for each group. There were 395 non-/modest-, 186 moderate-, and 112 super-responders. Super-responders were more likely to be female and to have nonischemic cardiomyopathy, lower creatinine, and lower pulmonary artery systolic pressure than non-/modest- and moderate-responders. Super-responders were also more likely to have lower LVEF than non-/modest-responders. There was no difference in NYHA functional class, mitral regurgitation grade, or tricuspid regurgitation grade between groups. Improvement in NYHA functional class (-0.9 +/- 0.9 vs -0.4 +/- 0.8 [P < .001] and -0.6 +/- 0.8 [P = .02]) and LVEDD (-8.7 +/- 9.9 mm vs -0.5 +/- 5.0 and -2.4 +/- 5.8 mm [P < .001 for both]) was greatest in super-responders. Kaplan-Meier survival analysis revealed that super-responders achieved better survival compared with non-/modest- (P < .001) and moderate-responders (P = .049). CONCLUSIONS: Improvement in HF symptoms and survival after CRT is proportionate to the degree of improvement in LV systolic function. Super-response is more likely in women, those with nonischemic substrate, and those with lower pulmonary artery systolic pressure. CI - Copyright (c) 2014 Elsevier Inc. All rights reserved. FAU - Killu, Ammar M AU - Killu AM AD - Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. FAU - Grupper, Avishay AU - Grupper A AD - Davidai Arrhythmia Center, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel. FAU - Friedman, Paul A AU - Friedman PA AD - Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. FAU - Powell, Brian D AU - Powell BD AD - Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. FAU - Asirvatham, Samuel J AU - Asirvatham SJ AD - Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. FAU - Espinosa, Raul E AU - Espinosa RE AD - Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. FAU - Luria, David AU - Luria D AD - Davidai Arrhythmia Center, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel. FAU - Rozen, Guy AU - Rozen G AD - Davidai Arrhythmia Center, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel. FAU - Buber, Jonathan AU - Buber J AD - Davidai Arrhythmia Center, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel. FAU - Lee, Ying-Hsiang AU - Lee YH AD - Cardiovascular Medicine, Mackay Memorial Hospital, Taipei, Taiwan. FAU - Webster, Tracy AU - Webster T AD - Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. FAU - Brooke, Kelly L AU - Brooke KL AD - Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. FAU - Hodge, David O AU - Hodge DO AD - Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota. FAU - Wiste, Heather J AU - Wiste HJ AD - Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota. FAU - Glikson, Michael AU - Glikson M AD - Davidai Arrhythmia Center, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel. FAU - Cha, Yong-Mei AU - Cha YM AD - Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. Electronic address: ycha@mayo.edu. LA - eng PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't DEP - 20140312 PL - United States TA - J Card Fail JT - Journal of cardiac failure JID - 9442138 SB - IM MH - Aged MH - Cardiac Resynchronization Therapy/mortality/*trends MH - Female MH - Follow-Up Studies MH - Heart Failure/*diagnosis/mortality/*therapy MH - Humans MH - Male MH - Middle Aged MH - Predictive Value of Tests MH - Retrospective Studies MH - Stroke Volume/*physiology MH - Survival Rate/trends MH - Treatment Outcome OTO - NOTNLM OT - Cardiac resynchronization OT - ICD OT - heart failure OT - pacemaker OT - treatment EDAT- 2014/03/19 06:00 MHDA- 2015/01/27 06:00 CRDT- 2014/03/18 06:00 PHST- 2013/05/27 00:00 [received] PHST- 2014/01/28 00:00 [revised] PHST- 2014/03/04 00:00 [accepted] PHST- 2014/03/18 06:00 [entrez] PHST- 2014/03/19 06:00 [pubmed] PHST- 2015/01/27 06:00 [medline] AID - S1071-9164(14)00094-3 [pii] AID - 10.1016/j.cardfail.2014.03.001 [doi] PST - ppublish SO - J Card Fail. 2014 Jun;20(6):379-86. doi: 10.1016/j.cardfail.2014.03.001. Epub 2014 Mar 12.